Many Illinois hospitals receive tax exemptions, but how much do they help their communities? New report takes a look
CHICAGO — Mount Sinai Hospital ranks the fourth highest among hospitals across 20 states for spending far more money on charity care and helping its community than what it saves through tax exemptions, according to a new report from the Lown Institute.
The hospital on Chicago's West Side spent an average of $78 million more a year on charity care and investing in its community than it saved from tax exemptions given to not-for-profit hospitals, between 2020 and 2022, according to the report from Lown, a Massachusetts-based think tank.
The report also identified Illinois hospitals that have done the opposite — spent less on charity care and community investment than what they saved through tax exemptions. Among the 10 biggest offenders in Illinois are Endeavor Health's hospitals in Evanston, Glenview, Highland Park and Skokie (as a group), as well as Advocate Christ Medical Center in Oak Lawn, Advocate Lutheran General Hospital in Park Ridge and Northwestern Memorial Hospital, among others, according to the report.
'There are a lot of hospitals that actually give back a lot more directly to their communities in meaningful ways than they enjoy in terms of the tax benefit or tax exemption, but there are unfortunately a lot of hospitals that are not, that are in deficit,' said Dr. Vikas Saini, president of the Lown Institute. 'We have a system where there's a lot of out of balance.'
The issue of whether hospitals should receive tax exemptions has been a topic of debate for years with some saying that many not-for-profit hospitals operate like profitable businesses and should have to pay more taxes. Hospital leaders, meanwhile, say they need the tax exemptions to continue to do important work and provide charitable care to patients who are unable to pay.
Nonprofit hospitals receive local, state and federal tax exemptions, but are required to report to the IRS each year how much money they spend to benefit their communities. In Illinois, not-for-profit hospitals don't have to pay property taxes as long as the value of their charitable services is at least equal to their property tax savings. Most hospitals in Illinois are not-for-profit.
The sometimes stark differences between hospitals in the same metropolitan area reflect a pattern in urban markets in which some hospitals with many resources 'are often inaccessible to low-income patients, while 'safety net' hospitals that serve more of these patients operate on thin margins,' according to the report.
Mount Sinai, which serves many patients who are uninsured or on Medicaid, has long been a leader when it comes to spending on charity care and on helping its community, said Dr. Ngozi Ezike, president and CEO of Sinai Chicago. In addition to caring for patients regardless of their health insurance coverage, the hospital also works to help patients such as by paying for their transportation to medical care and giving car seats to new parents in need.
'We are a safety net that doesn't do the wallet biopsy and takes care of everyone that comes through our doors,' Ezike said. 'If we're serious about narrowing some of the gaps that we see between the communities that we serve and much more affluent communities in this very same city of Chicago we need to do more, not less.'
Ezike acknowledged that it can be tough to spend so much on charity care and community support, and that the hospital is running in the red. She said the hospital relies on government funding, grants, philanthropy and corporate partnerships to help fill some of the gaps.
In response to the report's findings, Endeavor Health said in a statement Tuesday that the Lown Institute's methodology 'paints an incomplete and misleading picture.' Endeavor said Lown misrepresents the scope and impact of its work by lumping four of its hospitals together as one, and leaves out certain types of contributions Endeavor makes to its communities. Each of the hospitals surpass the state's requirements for community benefits, according to the statement.
'In 2023, Endeavor Health provided nearly $509 million in total community benefits, including charitable care, medical research, education, and initiatives addressing the social drivers of health,' Endeavor said in the statement. 'The Lown Institute applies a one-size-fits-all approach across nearly 2,000 hospitals that fails to account for local context or system-level investments.'
Advocate Health Care said in a statement Tuesday, 'We remain focused on redefining care for all, contributing $1.2 billion in charitable care and services across the Chicago area annually.' Northwestern Memorial did not respond to a request for comment Tuesday afternoon.
Across Illinois, Lown found that 63% of private, nonprofit hospitals saved more from tax exemptions than they spent on community investment. Lown analyzed data for 140 nonprofit hospitals in Illinois, using data from the IRS and the Centers for Medicare and Medicaid Services as well as municipal property data. Lown looked at more than 1,800 hospitals across 20 states.
In all, Illinois nonprofit hospitals received an average of $2.3 billion in tax exemptions each year between 2020 and 2022, according to the report. During that same time, Illinois nonprofit hospitals spent an average of $1.4 billion a year on charity care and community investments.
The four Endeavor hospitals saved an average of $152 million more a year in tax exemptions, as a group, than they spent on charity care and on community benefit, according to Lown. Advocate Christ saved an annual average of $71 million more in tax exemptions than it spent on charity care and community benefit, Advocate Lutheran saved an average of $68 million more, and Northwestern saved an average of $50 million a year more.
Chicago-area hospitals on the other end of the list – those that spent more on community investment than they saved through tax exemptions — include Franciscan Health Olympia Fields, St. Bernard Hospital and Health Care Center, Holy Cross Hospital and Endeavor Health Swedish Hospital, according to the report.
Olympia Fields spent an average of $16 million more a year on charity care and community benefit than it received through tax exemptions, St. Bernard spent an average of $12 million more a year, and Holy Cross and Swedish hospitals each spent $11 million more a year on average, according to the report.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Healthcare firm Totally collapses but divisions sold
Former NHS 111 urgent care provider Totally (TLY.L) has collapsed into administration, but said a deal to sell its main divisions will see the 'uninterrupted provision' of all its services. Totally has shed about half its workforce since last year and around 100 jobs are being put at risk as part of the deal announced on Monday. The Derby-based healthcare firm – which lost the NHS 111 support contract in February this year – has appointed Ernst & Young partners Tim Vance and Sam Woodward as joint administrators after failing to secure bids or strategic investors for the entire firm. It said that following the appointment, the sale of its selective care and corporate wellbeing subsidiaries, as well as the urgent care division, was completed to rival PHL Group. 'This transaction sees the continued and uninterrupted provision of all services previously delivered by the group,' Totally said. Totally employed around 1,400 staff at the end of March 2024. By the time it appointed administrators at EY on Friday, it had some 750 employees following two rounds of redundancies. More than 600 of those have been immediately transferred to the new owners following the sale to PHL – meaning that some 100 roles are at risk of redundancy. Mr Vance said: 'We are pleased to have agreed the sale of Totally which safeguards critical frontline NHS services and includes the retention of over 600 jobs.' Totally added: 'PHL Group will make separate announcements shortly, including communication with the customers, suppliers and employees of the elective care and urgent care divisions, and the corporate wellbeing business, which are all continuing to provide all services as normal following the transaction.' The company's failure comes after a difficult past year, with the firm losing the NHS 111 contract worth £13 million and then revealing last month it was facing a potential medical negligence claim related to an incident in January 2018. At the time, it warned the size of the liability for the claim could be more than the £10 million claim limit on its insurance policy. It launched a strategic review to look at options, including the sale of subsidiaries 'receiving strategic investment or undertaking some other form of comparable corporate action'. Shares in the firm plummeted at the time. On June 6, it announced its intention to appoint administrators after the review had failed to see any 'solvent' offers for parent firm Totally and suspended its shares from trading on London's junior Aim market. PHL – the buyer of its trading divisions – was launched in 2009 and runs services in the UK and overseas, including integrated urgent care, urgent treatment centres, surgical insourcing, custody healthcare, ADHD services and general practice.
Yahoo
an hour ago
- Yahoo
Tagomics awarded £860k grant for colorectal cancer diagnostic
Tagomics has been awarded £860,000 ($1.1m) from Innovate UK to develop a test for diagnosing early-stage colorectal cancer (CRC). The Cambridge, UK-based company said the money from the UK government innovation agency's Biomedical Catalyst programme would help fund a £1.2m project that is applying its Interlace multiomics workflow platform towards the detection of genetic and epigenetic mutations associated with CRC. This includes the development of new models for analysing patients' multiomic profiles to identify new disease biomarkers. Once the project concludes, a pilot study of the diagnostic test will be undertaken with the UK National Health Service (NHS). Led by Dr Arash Assadsangabi, consultant physician and gastroenterologist at Salford Royal NHS Foundation Trust, in collaboration with the Northern Care Alliance Research Collection biobank, the study will profile 250 patients suspected of having CRC to validate identified biomarkers and demonstrate multiomic profiling's efficacy in the early detection of the disease. Tagomics' chief scientific officer and co-founder, Dr Robert Neely said: 'We believe that the unique, information-rich dataset that Interlace provides us will be pivotal in detecting CRC at the earliest possible stages of development, enabling treatment of the cancer when it is most vulnerable to modern therapeutics, with the aim of dramatically improving patient outcomes.' Upon completion of the project, Tagomics will look to further expand the capabilities and applications of its Interlace platform with the support of Agilent Technologies, building on an established partnership that was key to the early development of the platform, Dr Neely added. The American Cancer Society estimates that there will be 107,320 new cases of colon cancer and 46,950 new cases of rectal cancer in 2025. According to GlobalData analysis, with early detection of CRC critical in reducing the disease's mortality rate, in vitro diagnostic (IVD) tests have a critical role to play in bridging the disease's screening gap, with company's such as Guardant Health at work on developing patient-first tests to create solutions that make patient care more accessible. Guardant's SHIELD test, which was approved by the US Food and Drug Administration (FDA) as a primary screening option for CRC in 2024, is intended to detect alterations in the blood associated with CRC. "Tagomics awarded £860k grant for colorectal cancer diagnostic" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
PeterMD Announces Official Website Update Featuring Telemedicine Services for Men's Hormone Health and TRT Support
National Platform Offers Secure Access to Physician-Led TRT and Hormone Health Consultations from Anywhere in the U.S. VERO BEACH, June 10, 2025 (GLOBE NEWSWIRE) -- PeterMD, a Florida-based men's health telemedicine provider, has updated its official website to spotlight its nationwide services focused on testosterone replacement therapy (TRT), hormone optimization, and performance support. Available in all 50 states, PeterMD offers direct-to-consumer access to licensed providers via a secure digital platform. According to the official website ( PeterMD allows adult men to privately consult with certified TRT specialists, receive personalized treatment plans based on lab results, and manage therapy from the comfort of home. Services are available without insurance requirements, with fast turnaround times and HIPAA-compliant care. 'PeterMD was built to eliminate unnecessary barriers to men's health,' said a company spokesperson. 'We believe in transparent, physician-directed care that gives men control over their wellness without waiting rooms or stigma.' The telemedicine platform includes options for lab testing coordination, treatment supervision, and ongoing patient support. Every consultation is handled by a qualified medical professional trained in men's hormone health. Once a plan is approved, therapies are shipped directly with complete oversight from the PeterMD medical team. The updated site features secure registration, FAQs, and real-time access to specialists. New clients are invited to speak directly with a TRT specialist by calling or texting 772-800-6133. For existing patients, dedicated support is available at 772-444-8669 or via email at support@ PeterMD patient support hours: Monday–Sunday: 7 AM – 7 PM EST (for new inquiries) Monday–Friday: 9 AM – 5 PM EST (for existing patients) About PeterMD PeterMD is a telehealth provider based in Vero Beach, Florida, offering customized men's hormone and wellness solutions across the United States. The platform connects users with medical experts for private, fast, and clinically guided treatment—empowering men to reclaim their energy, focus, and vitality through modern, accessible care. Product and Contact Information Brand: PeterMDWebsite: support@ (New Patients): 772-800-6133Phone (Support): 772-444-8669Mailing Address: 601 21st Street, Suite 300, Vero Beach, FL, United StatesBusiness Hours:New Patients: Monday–Sunday, 7 AM – 7 PM ESTSupport: Monday–Friday, 9 AM – 5 PM EST Disclaimer This release is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. All medical decisions should be made in consultation with a licensed healthcare provider. Availability of telemedicine services may vary by state. PeterMD complies with all applicable healthcare regulations. CONTACT: Email: support@ Phone (New Patients): 772-800-6133 Phone (Support): 772-444-8669Sign in to access your portfolio